FTSE techMARK Focus (T1X)

0.00
   
  • Closing Price Chg:
    -7.06
  • 52 Week High: 8,177.54
  • 52 Week Low: 5,701.68

Latest ShareCast News

Oxford Biomedica acquires US viral vector facility

By Iain Gilbert

Date: Tuesday 07 Oct 2025

(Sharecast News) - Cell and gene therapy outfit Oxford Biomedica said on Tuesday that it had agreed to acquire a viral vector manufacturing site in Rockville, Maryland, from ABL for $60m in cash, expanding its US footprint and strengthening its contract development and manufacturing offering.

FTSE techMARK Focus Regulatory News

Form 8.3 - SXS LN 08-Oct-2025 15:30 RNS
Form 8.3 - Spectris plc 08-Oct-2025 15:25 RNS
Form 8.3 - Spirent Communications plc 08-Oct-2025 15:25 Business Wire
Form 8.3 - Spectris plc 08-Oct-2025 15:25 Business Wire
Form 8.3 - NCC Group plc 08-Oct-2025 15:20 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Price Data

Price 8,097.78
Closing Price Change -7.06
% Change 0.00 %
07-Oct-25 Close 8,097.78

Top Risers

Price Change
FLTR 17,855.00p +2.7%
OXB 641.00p +2.4%
OXIG 2,025.00p +1.8%
BA. 2,022.00p +1.5%
APTD 302.00p +1.3%
QQ. 514.50p +1.1%
GNS 2,510.00p +0.4%
RSW 3,720.00p +0.3%
RCDO 430.00p +0.2%
CCC 2,782.00p +0.2%

Top Fallers

Price Change
NCC 143.60p -1.0%
TRD 303.33p -0.5%
XAR 118.50p -0.4%
SXS 4,090.00p -0.1%
SN. 1,335.50p -0.1%
XPP 918.00p -0.1%

Top of Page